Biotech Investors & VC Firms in China

238 firms in this list, with a median first check of $1M. 38 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
TusStar	Beijing	CN	Pre-Seed–Series A	—	+ Add to CRM
Sino Biopharmaceutical 11 people	Beijing	CN	Seed	—	+ Add to CRM
BioTrack Capital 7 people	Shanghai	CN	Pre-Seed–Series A	—	+ Add to CRM
MSA Capital 6 people · Leads rounds	Grand Cayman	CN	Pre-Seed–Late Stage	—	+ Add to CRM
Matrix Partners China 3 people · Leads rounds	Beijing	CN	Seed–Late Stage	—	+ Add to CRM
LYZZ Capital 5 people	Shanghai	CN	Seed–Series A	—	+ Add to CRM
Oriza Seed Capital (Oriza Yuandian) 9 people	Suzhou	CN	Pre-Seed–Series A	—	+ Add to CRM
Dalton Venture 8 people	Shanghai	CN	Seed–Series B	—	+ Add to CRM
K2VC 7 people	Beijing	CN	Pre-Seed–Series A	—	+ Add to CRM
Infotech Ventures	Beijing	CN	Seed–Late Stage	—	+ Add to CRM
Centurium Capital 3 people	Xiamen	CN	Growth–Late Stage	—	+ Add to CRM
SBCVC 6 people	Tortola	CN	Seed–Series B	—	+ Add to CRM
Lotus Lake Ventures 7 people · Leads rounds	Beijing	CN	Seed–Growth	—	+ Add to CRM
NewMargin Ventures 5 people	Shanghai	CN	Pre-Seed–Series B	$500K – $5M	+ Add to CRM
Axia8 Ventures 6 people	Shanghai	CN	Pre-Seed–Seed	—	+ Add to CRM
Apricot Capital 1 person · Follows rounds	Shanghai	CN	Seed–Series A	—	+ Add to CRM
YF Capital 4 people	Shanghai	CN	Series A–Late Stage	—	+ Add to CRM
Sangel Capital 2 people	Shenzhen	CN	Seed–Late Stage	—	+ Add to CRM
Sherpa Healthcare Partners 3 people · Follows rounds	Grand Cayman	CN	Seed–Late Stage	—	+ Add to CRM
Hanne Capital 2 people	Shanghai	CN	Seed–Growth	—	+ Add to CRM
Bits x Bites 3 people	Shanghai	CN	Pre-Seed–Series A	—	+ Add to CRM
Shanghai Creation Investment	Shanghai	CN	Late Stage	—	+ Add to CRM
South China Venture Capital 4 people	Shenzhen	CN	Seed–Growth	—	+ Add to CRM
Hangzhou Industrial Investment Group Follows rounds	Hangzhou	CN	—	—	+ Add to CRM